News

Adverum Biotechnologies Gears Up for Key Investor Conferences

Adverum Biotechnologies Gears Up for Key Investor Conferences

Adverum Biotechnologies Prepares for Major Investor Conferences

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is in the spotlight as it gears up to participate in several important investor conferences. These events will showcase the company's innovative approaches and future projects. As a clinical-stage organization, Adverum is at the forefront of gene therapy, aiming to set a new standard for treating common ocular diseases.

Overview of Upcoming Conferences

The company has revealed its involvement in several key events that will facilitate connections with investors and allow them to share their vision moving forward. The conferences include:

H.C. Wainwright 26th Annual Global Investment Conference

Scheduled for a Tuesday in mid-September, Adverum will present at this significant conference at 3:30 p.m. ET. This event provides an opportunity for the company to showcase its groundbreaking projects in gene therapy.

Chardan’s 8th Annual Genetic Medicines Conference

On October 1st, Adverum Biotechnologies will take the stage at this important conference at 8:00 a.m. ET. This event will further highlight the company's progress in genetic therapies.

UBS Virtual Ophthalmology Day

Following the Chardan conference, Adverum will participate in the UBS Virtual Ophthalmology Day on a Wednesday at 10:30 a.m. ET. This virtual format allows for broader engagement as digital participation continues to rise, enabling more people to connect with Adverum's innovations.

Accessing Webcasts

Investors and those interested can access on-demand webcasts of these presentations through the Events and Presentations section on Adverum’s website. Each presentation will be available for replay for at least 30 days, allowing audiences to revisit valuable insights.

About Adverum Biotechnologies

Adverum Biotechnologies is focused on transforming the treatment landscape for ocular diseases through innovative gene therapy. Utilizing its proprietary intravitreal (IVT) platform, the company is developing one-time therapies that could reduce the need for frequent ocular injections. Their leading candidate, ixoberogene soroparvovec (Ixo-vec), targets conditions such as neovascular or wet age-related macular degeneration.

In addition to improving existing treatments, Adverum aims to redefine the standard of care, enhancing patients' quality of life and striving for long-lasting vision restoration. By addressing the limitations of current therapies in the ocular field, Adverum Biotechnologies is well-positioned to make a significant societal impact.

Contact Information

For more information, interested individuals can contact Adverum's Investor Relations via email at ir@adverum.com.

Frequently Asked Questions

What is Adverum Biotechnologies focused on?

Adverum is dedicated to utilizing gene therapy to tackle prevalent ocular diseases, with the goal of providing sustainable treatment options for patients.

When will Adverum participate in investor conferences?

Adverum is set to present at several investor conferences in September and October, where they will provide important updates on their advancements.

How can I access the investor presentations?

The presentations will be available on-demand on Adverum's website in the Events and Presentations section for at least 30 days following each event.

What is ixoberogene soroparvovec?

ixoberogene soroparvovec (Ixo-vec) is Adverum’s leading gene therapy candidate intended for the one-time treatment of wet age-related macular degeneration.

How does Adverum plan to address ocular diseases?

Adverum is focused on developing durable therapies that allow patients to avoid repeated injections, thus simplifying the treatment process and improving patient care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 148

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 132

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 183

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 112

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 170

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 115

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Updated Category News Views 175

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 188

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 174

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyramid Global Hospitality Welcomes Anthony Torres Amid Award Success

Updated Category News Views 281

Pyramid Global Hospitality Welcomes a New Leader The renowned hospitality management company, Pyramid Global Hospitality, has recently appointed Anthony Torres as its vice president of food and beverage. In this pivotal role, he will oversee the culinary vision that has underpinned the company’s award-winning reputation in the hospitality industry. Celebrating Culinary...

Continue Reading
Shamari Reid's Audiobook Earns Audie Award Nomination

Updated Category News Views 117

Shamari Reid's Audiobook Earns Audie Award Nomination Heinemann, a respected name in educational publishing, has announced that Shamari Reid's audiobook, Humans Who Teach: A Guide for Centering Love, Justice, and Liberation in Schools, has been nominated for the prestigious Audie Award in the business and personal development category. This recognition highlights the...

Continue Reading
Azazie's Summer RSVP Collection: Versatility Unleashed

Updated Category News Views 19

The Shift from Singular to Seasonal Dressing You ever get that feeling when you’re dressing for a season full of events, rather than pinning everything on just one big day? That’s what Azazie’s latest move is about, tearing up those old pages of the calendar marked just for weddings and making room for the whole shebang—every lunch, night out, and festive fling...

Continue Reading
Growing Demand for Automated Boarding Gates: Market Trends

Updated Category News Views 197

Overview of the Automatic Boarding Gates Market The automatic boarding gates market is on the rise, with expectations to reach $132.8 million by the end of the forecast period in 2032. Key factors driving this growth include an increase in air passenger traffic, ongoing technological advancements, and heightened security needs in the industry. A recent report shows that...

Continue Reading
Stride, Inc.'s Compliance Issues Under Investigation by SEC

Updated Category News Views 330

Stride, Inc. Faces Serious Investor Scrutiny Shares of Stride, Inc. (NYSE: LRN), a notable player in the educational technology sector, have seen a sharp decline in value due to recent allegations made against the company. The complaints, originating from a New Mexico school district, allege serious infractions, including fraudulent practices and conflicts of interest,...

Continue Reading